Å·²©¼¯ÍÅר¼ÒØÁ¢×ãÁÙ´²ÅàÑø¸ßˮƽÁÙ´²Å·²©¼¯ÍŹÙÍøÑ§È˲šª¡ª´ÞÒ»Ãñ½ÌÊÚÍŶÓÔÚJACCÆÚ¿¯·¢±íÆÀÊöÎÄÕÂ
·¢²¼Ê±¼ä£º
2021-11-19
À´Ô´£º
ÎÄÕÂ×ªÔØ×Ô±±¾©´óѧŷ²©¼¯ÍŹÙÍøÑ§ÔºÎ¢ÐŹ«ÖںŠ£¬°æÈ¨¹éÔ×÷ÕßËùÓС£
2021Äê11ÔÂ13ÈÕ£¬Journal of the American College of CardiologyÔÓÖ¾£¨JACC£¬IF = 24.1£©¿¯µÇÁËÎÒԺŷ²©¼¯ÍŹÙÍøÊ¹ÜÀíÓëÁÙ´²Å·²©¼¯ÍŹÙÍøÑ§Ïµ´ÞÒ»Ãñ½ÌÊÚÍŶÓÕë¶Ô¸ÃÔÓÖ¾“Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary Revascularization”Ò»ÎĵįÀÊöÎÄÕ£º“Does repeat revascularization introduce bias for reducing mortality in antiplatelet therapy group?”¡£ÎÄÕ²ûÊöÁ˹Ú×´¶¯ÂöѪÔËÖØ½¨Êõ£¨°üÀ¨¾Æ¤¹Ú×´¶¯Âö½éÈëÖÎÁÆ£¨PCI£©ºÍ¹Ú×´¶¯Âö´îÇÅÊõ£¨CABG£©£©ºó»¼ÕßÊÇ·ñÐÐÔÙ´ÎѪÔËÖØ½¨Êõ¶Ô¿¹ÑªÐ¡°åÅ·²©¼¯ÍŹÙÍøÎïÖÎÁÆÆÀ¼ÛµÄÆ«ÒзçÏÕ£¬Ç¿»¯¿¹ÑªÐ¡°åÅ·²©¼¯ÍŹÙÍøÎïÁÆÐ§ÆÀ¼ÛµÄÑϽ÷ÐÔ¡£

¸ÃÆÀÊöÎÄÕµĵÚÒ»×÷ÕßΪÎÒÔºÁÙ´²Å·²©¼¯ÍŹÙÍøÑ§×¨Òµ¶þÄ꼶˶ʿÉúÀîÎĻۣ¬µ¼Ê¦Îª´ÞÒ»Ãñ½ÌÊÚÍŶӵÄÏòÙ»Ö÷ÈÎÅ·²©¼¯ÍŹÙÍøÊ¦¡£×÷ΪÔÚ¶ÁÑо¿ÉúÔÚ¹ú¼Ê¶¥¼¶µÄÐÄѪ¹ÜÆÚ¿¯·¢±íÆÀÊöÎÄÕ£¬Ò»·½ÃæÊÇÆäÔÚÁÙ´²Êµ¼ù¹ý³ÌÖеIJ»¶Ï»ýÀۺͶÔÁÙ´²Â·¾¶¡¢¹úÄÚÍâÖ¸Äϵijä·Öѧϰ£»ÁíÒ»·½ÃæÔòÐèÒª²ÎÓëÁÙ´²Ñо¿£¬ÕÆÎÕÁÙ´²Ñо¿µÄ·½·¨Ñ§£¬ÅàÑø²¢¾ß±¸·¢ÏÖºÍÌá³öÎÊÌâ¡¢Ñо¿ºÍ½â¾öÎÊÌâµÄÄÜÁ¦¡£
ÎÄÕÂÁ´½Ó
https://doi.org/10.1016/j.jacc.2021.08.063
Ê®ÓàÄêÀ´£¬´ÞÒ»Ãñ½ÌÊÚÍŶÓÔÚÁÙ´²Å·²©¼¯ÍŹÙÍøÑ§×¨ÒµÑо¿ÉúµÄÅàÑøÉϲ»¶Ï̽Ë÷£¬×¢ÖØÅàÑøÑ§ÉúµÄÁÙ´²Êµ¼ùÄÜÁ¦µÄͬʱ£¬Ò²Ì½Ë÷ÔöǿѧÉú¶ÔÅ·²©¼¯ÍŹÙÍøÎïÖÎÁÆÏà¹ØÁÙ´²ºÍ»ù´¡Ñо¿µÄÄÜÁ¦¡£ÁÙ´²Ö¸ÄϺÍÕïÁƳ£¹æµÄÐγɶ¼ÊÇÒÔһϵÁÐÁÙ´²Ñо¿¡¢ÁÙ´²ÊÔÑéΪ»ù´¡£»Å·²©¼¯ÍŹÙÍøÎï·¢ÏÖºÍ×ßÏòÁÙ´²¶¼ÊÇÒÔһϵÁÐÉúÎï¡¢»¯Ñ§¡¢Å·²©¼¯ÍŹÙÍøÀíµÈʵÑéΪ»ùʯ£¬Å·²©¼¯ÍŹÙÍøÎïÖÎÁƵÄÕÆÎÕºÍÁé»îÓ¦Óã¬Àë²»¿ª¶ÔÅ·²©¼¯ÍŹÙÍøÎï×÷ÓÃÔÀí¡¢Å·²©¼¯ÍŹÙÍøÎï´úл¡¢Å·²©¼¯ÍŹÙÍøÎïÏ໥×÷ÓõȵÄÀí½â¡£ÒÔÉ϶¼ÊÇÁÙ´²Å·²©¼¯ÍŹÙÍøÑ§×¨ÒµÑ§ÉúµÄÅàÑøÖØµã£¬Ò²ÊÇÁÙ´²Å·²©¼¯ÍŹÙÍøÊ¦ÔÚÁÙ´²·¢»Ó²»¿ÉÌæ´ú×÷ÓõĻùʯ¡£
ʵʩ½¡¿µÖйúÕ½ÂÔ£¬ÒªÇóÌṩȫ·½Î»¡¢È«ÖÜÆÚµÄ½¡¿µ·þÎñ£¬½¨Á¢ÓÅÖʸßЧµÄÒ½ÁÆÎÀÉú·þÎñÌåϵ¡£Å·²©¼¯ÍŹÙÍøÊ¦×÷ΪҽÁÆÍŶӵÄÖØÒª³ÉÔ±£¬ÔÚ±£Ö¤»¼ÕßÓÃÅ·²©¼¯ÍŹÙÍø°²È«¡¢´Ù½øºÏÀíÓÃÅ·²©¼¯ÍŹÙÍø¡¢Î¬»¤ÈËÃñȺÖÚ½¡¿µÖУ¬·¢»Ó×ÅÖØÒª×÷Ó᣸ßÖÊÁ¿µÄÅ·²©¼¯ÍŹÙÍøÑ§·þÎñºÍ¸ßˮƽµÄÅ·²©¼¯ÍŹÙÍøÊ¦¶ÓÎéÊÇÓÅÖʸßЧµÄÒ½ÁÆÎÀÉú·þÎñÌåϵµÄÖØÒª²¿·Ö¡£±±¾©´óѧÁÙ´²Å·²©¼¯ÍŹÙÍøÑ§½ÌÓý²»¶Ï̽Ë÷Óë´´ÐÂÅàÑø·½Ê½£¬¼á³ÖÒÔÅàÑø¼æ¾ßÅ·²©¼¯ÍŹÙÍøÑ§×ÛºÏʵ¼ù¼¼ÄÜÓëÅ·²©¼¯ÍŹÙÍøÆ·ÆÀ¼ÛÑо¿ÄÜÁ¦µÄ¸ßËØÖÊÅ·²©¼¯ÍŹÙÍøÑ§È˲ÅΪĿ±ê£¬½¨Á¢ÆðÁÙ´²ÓëÅ·²©¼¯ÍŹÙÍøÑ§µÄ¼á¹ÌÇÅÁº£¬ÍƽøÅ·²©¼¯ÍŹÙÍøÊ¦ÔÚ½¡¿µÖйúÕ½ÂÔµÄʵʩ¹ý³ÌÖв»¶Ï·¢»Ó»ý¼«×÷Óá£
Å·²©¼¯ÍŹÙÍøÊ¹ÜÀíÓëÁÙ´²Å·²©¼¯ÍŹÙÍøÑ§Ïµ